sábado, 14 de noviembre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 13, 2026

Can Strong iPhone and Mac Portfolio Help Apple Stock Recover in FY26?

View original at finance.yahoo.com
Can Strong iPhone and Mac Portfolio Help Apple Stock Recover in FY26? Apple AAPL shares have dropped 4.2% year to date (YTD), outperforming close peers such as HP HPQ and Microsoft MSFT but lagging Amazon AMZN…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The Zacks Consensus Estimate for Apple's fiscal 2026 earnings is $8.40 per share, indicating 12.6% growth from fiscal 2025

    60% confidence

  • Worldwide PC shipments totaled 62.8 million units in the first quarter of 2026, up 4% year over year

    60% confidence

  • Samsung's shipments declined 6% year over year with 20% market share

    60% confidence

  • Lenovo led PC market with 26.5% market share, trailed by HP and Dell Technologies with 19.3% and 16.5%, respectively. Apple had a 10.6% market share

    60% confidence

  • Global smartphone shipments declined 6% year over year in the first quarter of 2026, with Apple leading with 21% market share and shipments growing 5% year over year, driven by strong iPhone 17 demand and improved performance in China

    60% confidence

  • The Zacks Consensus Estimate for Apple's fiscal 2026 revenues is pegged at $461.68 billion, indicating 10.94% growth over fiscal 2025

    60% confidence

  • Apple shares are overvalued, as suggested by a Value Score of F

    60% confidence

Data points we hold from this source

HP Inc. · market share19.3 percent
HP Inc. · pe ratio6.37 ratio
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com
Can Strong iPhone and Mac Portfolio Help Apple Stock Recover in FY26? — Source | Via News | es.VIA.NEWS